Arnold von Eckardstein

37.2k total citations · 3 hit papers
419 papers, 22.2k citations indexed

About

Arnold von Eckardstein is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Arnold von Eckardstein has authored 419 papers receiving a total of 22.2k indexed citations (citations by other indexed papers that have themselves been cited), including 179 papers in Surgery, 142 papers in Endocrinology, Diabetes and Metabolism and 114 papers in Molecular Biology. Recurrent topics in Arnold von Eckardstein's work include Diabetes, Cardiovascular Risks, and Lipoproteins (113 papers), Lipoproteins and Cardiovascular Health (99 papers) and Cholesterol and Lipid Metabolism (71 papers). Arnold von Eckardstein is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (113 papers), Lipoproteins and Cardiovascular Health (99 papers) and Cholesterol and Lipid Metabolism (71 papers). Arnold von Eckardstein collaborates with scholars based in Switzerland, Germany and United States. Arnold von Eckardstein's co-authors include Gerd Assmann, Lucia Rohrer, H. Schulte, Jerzy–Roch Nofer, Thorsten Hornemann, Harald Funke, F. C. W. Wu, Martin Hersberger, Katharina Rentsch and Ralf Junker and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Arnold von Eckardstein

409 papers receiving 21.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High Density Lipoproteins and Arteriosclerosis

2001 560 citations Arnold von Eckardstein, Gerd Assmann et al. profile →
HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research

2021 198 citations Anand Rohatgi, Marit Westerterp et al. Circulation profile →
High-density lipoprotein revisited: biological functions and clinical relevance

2022 185 citations Arnold von Eckardstein, Alan T. Remaley et al. European Heart Journal profile →

Peers

Countries citing papers authored by Arnold von Eckardstein

Since Specialization

Citations

This map shows the geographic impact of Arnold von Eckardstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnold von Eckardstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnold von Eckardstein more than expected).

Fields of papers citing papers by Arnold von Eckardstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnold von Eckardstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnold von Eckardstein. The network helps show where Arnold von Eckardstein may publish in the future.

Co-authorship network of co-authors of Arnold von Eckardstein

This figure shows the co-authorship network connecting the top 25 collaborators of Arnold von Eckardstein. A scholar is included among the top collaborators of Arnold von Eckardstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnold von Eckardstein. Arnold von Eckardstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ceramides in cardiovascular disease: emerging role as independent risk predictors and novel therapeutic targets 2025 ·Cardiovascular Research ·Roland Klingenberg, Andreas Leiherer, Dobromir Dobrev, Juan Carlos Kaski, Bodo Levkau, Winfried März, Samuel Sossalla, Arnold von Eckardstein, Heinz Drexel	2
2	Discordance between LDL-C and apolipoprotein B is associated with large-artery-atherosclerosis ischemic stroke in patients ⩽70 years of age 2024 ·European Stroke Journal ·(unknown), (unknown), Joanna Gawinecka, Felix Groß, Markus Arnold, (unknown), (unknown), (unknown), Thomas Pokorny, Tolga Dittrich, (unknown), Marcel Arnold, Mirjam Christ‐Crain, Arnold von Eckardstein, Katharina Rentsch, Mira Katan, Gian Marco De Marchis	5
3	Interassay Variability and Clinical Implications of Five Different Prostate-specific Antigen Assays 2024 ·European Urology Open Science ·(unknown), (unknown), Laura Zuluaga, (unknown), Michael Müntener, Etienne Xavier Keller, Katharina Spanaus, Arnold von Eckardstein, Michael A. Gorin, Cédric Poyet	3
4	Body temperature, systemic inflammation and risk of adverse events in patients with acute coronary syndromes 2024 ·European Journal of Clinical Investigation ·(unknown), (unknown), Simon Kraler, (unknown), Christian M. Matter, Florian A. Wenzl, Arnold von Eckardstein, Lorenz Räber, François Mach, Slayman Obeid, Christian Templin, Thomas F. Lüscher, David Niederseer, (unknown)	5
5	Effects of vitamin D, omega-3 and a simple strength exercise programme in cardiovascular disease prevention: The DO-HEALTH randomized controlled trial 2024 ·The journal of nutrition health & aging ·(unknown), Angélique Sadlon, Caroline de Godoi Rezende Costa Molino, Walter C. Willett, JoAnn E. Manson, Bruno Vellas, Elisabeth Steinhagen‐Thiessen, Arnold von Eckardstein, Frank Ruschitzka, René Rizzoli, José António Pereira da Silva, Reto W. Kressig, John А. Kanis, E. John Orav, Andreas Egli, Heike A. Bischoff‐Ferrari	6
6	Growth differentiation factor-15 and prediction of cancer-associated thrombosis and mortality: a prospective cohort study 2023 ·Journal of Thrombosis and Haemostasis ·Stephan Nopp, Florian Moik, Simon Kraler, (unknown), Matthias Preusser, Arnold von Eckardstein, Ingrid Pabinger, Thomas F. Lüscher, Cihan Ay	4
7	Dipeptidyl peptidase 3 plasma levels predict cardiogenic shock and mortality in acute coronary syndromes 2023 ·European Heart Journal ·Florian A. Wenzl, Francesco Bruno, Simon Kraler, Roland Klingenberg, Alexander Akhmedov, Stefano Ministrini, Karine Santos, (unknown), (unknown), David Niederseer, Robert Manka, Andreas Bergmann, Giovanni G. Camici, Arnold von Eckardstein, Barbara E. Stähli, Olivier Müller, Marco Roffi, Lorenz Räber, Thomas F. Lüscher	27
8	Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts premature death in acute coronary syndromes 2022 ·European Heart Journal ·Simon Kraler, Florian A. Wenzl, Georgios Georgiopoulos, Slayman Obeid, Luca Liberale, Arnold von Eckardstein, Olivier Müller, François Mach, Lorenz Räber, Sylvain Losdat, Martin Schmiady, Konstantinos Stellos, Kimon Stamatelopoulos, Giovanni G. Camici, (unknown), Francesco Paneni, Alexander Akhmedov, Thomas F. Lüscher	34
9	Metabolism of HSAN1- and T2DM-associated 1-deoxy-sphingolipids inhibits the migration of fibroblasts 2021 ·Journal of Lipid Research ·Gergely Karsai, R. Steiner, Andres Kaech, Museer A. Lone, Arnold von Eckardstein, Thorsten Hornemann	10
10	Cysteine‐Rich Angiogenic Inducer 61 Improves Prognostic Accuracy of GRACE (Global Registry of Acute Coronary Events) 2.0 Risk Score in Patients With Acute Coronary Syndromes 2021 ·Journal of the American Heart Association ·Roland Klingenberg, Soheila Aghlmandi, Lorenz Räber, Alexander Akhmedov, Bariş Gencer, David Carballo, David Nanchen, Heiner C. Bucher, Nicolas Rodondi, François Mach, Stephan Windecker, Ulf Landmesser, Arnold von Eckardstein, Christian W. Hamm, Thomas F. Lüscher, Christian M. Matter	5
11	HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research breakdown → 2021 ·Circulation ·Anand Rohatgi, Marit Westerterp, Arnold von Eckardstein, Alan T. Remaley, Kerry‐Anne Rye	198
12	Subunit composition of the mammalian serine-palmitoyltransferase defines the spectrum of straight and methyl-branched long-chain bases 2020 ·Proceedings of the National Academy of Sciences ·Museer A. Lone, Andreas J. Hülsmeier, Essa M. Saied, Gergely Karsai, Christoph Arenz, Arnold von Eckardstein, Thorsten Hornemann	60
13	FADS3 is a Δ14Z sphingoid base desaturase that contributes to gender differences in the human plasma sphingolipidome 2019 ·Journal of Biological Chemistry ·Gergely Karsai, Museer A. Lone, Zoltán Kutalik, J. Thomas Brenna, Hongde Li, Duojia Pan, Arnold von Eckardstein, Thorsten Hornemann	70
14	Intra-individual variation of plasma trimethylamine-N-oxide (TMAO), betaine and choline over 1 year 2016 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Tilman Kühn, Sabine Rohrmann, Disorn Sookthai, Theron Johnson, Verena Katzke, Rudolf Kaaks, Arnold von Eckardstein, Daniel J. Müller	88
15	High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease 2004 ·Current Opinion in Lipidology ·Lucia Rohrer, Martin Hersberger, Arnold von Eckardstein	136
16	Plasma and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-I 1998 ·Journal of Lipid Research ·Arnold von Eckardstein, (unknown), (unknown), Michael Walter, John J.P. Kastelein, Jürgen Geisel, José T. Real, Roberto Miccoli, G Noseda, (unknown), Gerd Assmann	35
17	Phenotype dependent differences in apolipoprotein E gene expression and protein secretion in human monocyte-derived macrophages 1996 ·Circulation ·Paul Cullen, Andrea Cignarella, Arnold von Eckardstein, Susanne Mohr, Gerd Assmann	3
18	Genetic and phenotypic heterogeneity in familial lecithin: cholesterol acyltransferase (LCAT) deficiency. Six newly identified defective alleles further contribute to the structural heterogeneity in this disease. 1993 ·Journal of Clinical Investigation ·Harald Funke, Arnold von Eckardstein, P. Haydn Pritchard, A E Hornby, Heiko Wiebusch, Corradino Motti, Michael R. Hayden, C. Dachet, B Jacotot, Ulrik Gerdes	72
19	A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and corneal opacities. 1991 ·Journal of Clinical Investigation ·Harald Funke, Arnold von Eckardstein, P. Haydn Pritchard, Michael Karas, J J Albers, Gerd Assmann	104
20	Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I. 1989 ·Journal of Clinical Investigation ·Arnold von Eckardstein, Harald Funke, (unknown), Klaus Altland, A. Benninghoven, Gerd Assmann	80

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact